Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381377950> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W4381377950 abstract "Small molecule DYRK1A inhibitors induce adult human beta cell proliferation and expand human beta cell mass. Harmine also enhances differentiation and function in human beta cells in vitro and in vivo, increasing expression of key beta cell genes. It is unknown whether this “pro-differentiation effect” is a feature of all DYRK1A inhibitors. We compared harmine, 2-2c, 5-Iodotubericidin (5-IT), GNF4877, INDY, CC-401 and Leucettine-41 at doses that maximally drive human beta cell proliferation. As anticipated, harmine, 2-2c and 5-IT all increased expression of PDX1, MAFA, NKX6.1, SLC2A2, PCSK1, MAFB, SIX2, SLC30A8, and ENTPD3. These effects were observed in normal human islets as well as in islets from donors with T2D. Surprisingly, in simultaneous experiments, the DYRK1A inhibitors GNF4877, INDY, CC-401 and Leucettine failed to induce these beta cell differentiation markers. The pro-differentiation effect of harmine was independent of DYRK1A inhibition: silencing DYRK1A in human islets induced beta cell proliferation, but had no effect on differentiation; harmine treatment in DYRK1A-silenced islets restored beta cell pro-differentiation effects. The pro-differentiation effect was also independent of NFAT signaling and DREAM Complex effects, since NFAT overexpression, or p130, p107, E2F4 and E2F5 silencing had no effect on beta cell differentiation. Similarly, silencing other known harmine targets (DYRK2, 3, 4, the CLK and HIPK family) had no effect on either human beta cell differentiation nor proliferation. In summary, harmine, 2-2c and 5-IT are unique among the DYRK1A inhibitor family in their simultaneous ability to enhance both beta cell proliferation and differentiation. While the beta cell proliferation is mediated by DYRK1A inhibition, the pro-differentiation effects of harmine, 2-2c and 5-IT are distinct, and unexplained in mechanistic terms. These considerations have important implications for DYRK1A inhibitor drug development. Disclosure P. Wang: None. K. Kumar: None. H. Liu: None. O. Wood: None. E. Karakose: None. L. Choleva: None. L. Lambertini: None. A. Garcia-Ocana: Consultant; Sun Pharmaceutical Industries Ltd. R.J. DeVita: None. A.F. Stewart: None." @default.
- W4381377950 created "2023-06-21" @default.
- W4381377950 creator A5000480657 @default.
- W4381377950 creator A5006140692 @default.
- W4381377950 creator A5006715926 @default.
- W4381377950 creator A5029845343 @default.
- W4381377950 creator A5038868609 @default.
- W4381377950 creator A5047201441 @default.
- W4381377950 creator A5056831085 @default.
- W4381377950 creator A5058318565 @default.
- W4381377950 creator A5079417201 @default.
- W4381377950 creator A5083227205 @default.
- W4381377950 date "2023-06-20" @default.
- W4381377950 modified "2023-10-18" @default.
- W4381377950 title "349-OR: Selected DYRK1A Inhibitors Simultaneously Drive Both Human Beta-Cell Proliferation and Differentiation" @default.
- W4381377950 doi "https://doi.org/10.2337/db23-349-or" @default.
- W4381377950 hasPublicationYear "2023" @default.
- W4381377950 type Work @default.
- W4381377950 citedByCount "0" @default.
- W4381377950 crossrefType "journal-article" @default.
- W4381377950 hasAuthorship W4381377950A5000480657 @default.
- W4381377950 hasAuthorship W4381377950A5006140692 @default.
- W4381377950 hasAuthorship W4381377950A5006715926 @default.
- W4381377950 hasAuthorship W4381377950A5029845343 @default.
- W4381377950 hasAuthorship W4381377950A5038868609 @default.
- W4381377950 hasAuthorship W4381377950A5047201441 @default.
- W4381377950 hasAuthorship W4381377950A5056831085 @default.
- W4381377950 hasAuthorship W4381377950A5058318565 @default.
- W4381377950 hasAuthorship W4381377950A5079417201 @default.
- W4381377950 hasAuthorship W4381377950A5083227205 @default.
- W4381377950 hasConcept C104317684 @default.
- W4381377950 hasConcept C119056186 @default.
- W4381377950 hasConcept C134018914 @default.
- W4381377950 hasConcept C148738053 @default.
- W4381377950 hasConcept C165220095 @default.
- W4381377950 hasConcept C184235292 @default.
- W4381377950 hasConcept C189938988 @default.
- W4381377950 hasConcept C199360897 @default.
- W4381377950 hasConcept C2776174256 @default.
- W4381377950 hasConcept C2776828364 @default.
- W4381377950 hasConcept C2777736865 @default.
- W4381377950 hasConcept C2779306644 @default.
- W4381377950 hasConcept C2781450507 @default.
- W4381377950 hasConcept C41008148 @default.
- W4381377950 hasConcept C55493867 @default.
- W4381377950 hasConcept C62112901 @default.
- W4381377950 hasConcept C86339819 @default.
- W4381377950 hasConcept C86803240 @default.
- W4381377950 hasConcept C95444343 @default.
- W4381377950 hasConcept C98274493 @default.
- W4381377950 hasConceptScore W4381377950C104317684 @default.
- W4381377950 hasConceptScore W4381377950C119056186 @default.
- W4381377950 hasConceptScore W4381377950C134018914 @default.
- W4381377950 hasConceptScore W4381377950C148738053 @default.
- W4381377950 hasConceptScore W4381377950C165220095 @default.
- W4381377950 hasConceptScore W4381377950C184235292 @default.
- W4381377950 hasConceptScore W4381377950C189938988 @default.
- W4381377950 hasConceptScore W4381377950C199360897 @default.
- W4381377950 hasConceptScore W4381377950C2776174256 @default.
- W4381377950 hasConceptScore W4381377950C2776828364 @default.
- W4381377950 hasConceptScore W4381377950C2777736865 @default.
- W4381377950 hasConceptScore W4381377950C2779306644 @default.
- W4381377950 hasConceptScore W4381377950C2781450507 @default.
- W4381377950 hasConceptScore W4381377950C41008148 @default.
- W4381377950 hasConceptScore W4381377950C55493867 @default.
- W4381377950 hasConceptScore W4381377950C62112901 @default.
- W4381377950 hasConceptScore W4381377950C86339819 @default.
- W4381377950 hasConceptScore W4381377950C86803240 @default.
- W4381377950 hasConceptScore W4381377950C95444343 @default.
- W4381377950 hasConceptScore W4381377950C98274493 @default.
- W4381377950 hasIssue "Supplement_1" @default.
- W4381377950 hasLocation W43813779501 @default.
- W4381377950 hasOpenAccess W4381377950 @default.
- W4381377950 hasPrimaryLocation W43813779501 @default.
- W4381377950 hasRelatedWork W1989238979 @default.
- W4381377950 hasRelatedWork W2017372504 @default.
- W4381377950 hasRelatedWork W2106029142 @default.
- W4381377950 hasRelatedWork W2160082928 @default.
- W4381377950 hasRelatedWork W2886244301 @default.
- W4381377950 hasRelatedWork W3004297425 @default.
- W4381377950 hasRelatedWork W3030100789 @default.
- W4381377950 hasRelatedWork W4309082128 @default.
- W4381377950 hasRelatedWork W4366283356 @default.
- W4381377950 hasRelatedWork W2181918187 @default.
- W4381377950 hasVolume "72" @default.
- W4381377950 isParatext "false" @default.
- W4381377950 isRetracted "false" @default.
- W4381377950 workType "article" @default.